// company-profile

Apimeds Pharmaceuticals US, Inc.

APUS
ExchangeNYSESectorPharmaceutical PreparationsInc.DEFilings24Insiders8
// api This Apimeds Pharmaceuticals US, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for APUS in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Apimeds Pharmaceuticals US, Inc. as of 2026-03-31

— stable
Total reported AUM
$759,948
QoQ change
Reporting period
2026-03-31
#1
Hemenway Trust Co LLC
CIK 1494234
$490,296
274K shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$171,617
96K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$66,499
37K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Nov 11, 2025Koo JakapAPUS
Award
10,000$0.00$0K
Nov 11, 2025Yoon HankilAPUS
Award
10,000$0.00$0K
Nov 11, 2025O'DONNELL CAROL AAPUS
Award
10,000$0.00$0K
Nov 11, 2025Kogan Elona Esq.APUS
Award
10,000$0.00$0K
Nov 11, 2025Weintraub BennettAPUS
Award
10,000$0.00$0K

22 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.